Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4224 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Glaxo heart drug shown to be safer than rival

This landmark head-to-head trial, evaluated more than 20,000 patients with ACS, and was presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden. Arixtra was as

Study highlights cost of new drugs

The rising cost of using these ‘me-too’ drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British

Scientists develop fungus-fighting vaccine

Although these fungi pose little threat to people with healthy immune systems, they can cause fatal infections in those whose immune systems have been weakened by cancer treatments

Amgen initiates study into heart failure and anemia

“Numerous epidemiological studies have consistently demonstrated that lower hemoglobin values, reflecting a condition known as anemia, are associated with increased hospitalizations and mortality in heart failure patients,” said